logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

AACR 2018 — CDX-301 and SBRT exert synergistic effect in advanced NSCLC

CDX-301 (FLT3 ligand) combined with stereotactic radiotherapy led to frequent abscopal effects and high rate of PFS.